|
Market Closed -
Nasdaq Stockholm
17:00:00 11/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.040 SEK | -1.45% |
|
+0.99% | +7.37% |
| 09-02 | Enzymatica CEO buys additional shares | FW |
| 09-01 | Enzymatica CEO buys 33 384 shares | FW |
| Market Cap | 495M 427M 404M 366M 687M 47.31B 691M 4.8B 1.84B 24.04B 1.86B 1.82B 76.04B | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 463M 399M 378M 342M 642M 44.24B 646M 4.48B 1.72B 22.48B 1.74B 1.7B 71.11B | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| ENZY | Delayed | |
Deutsche Boerse AG
| EN9 | Delayed | |
|
Börse Stuttgart
| EN9 | Delayed | |
|
Boerse Muenchen
| EN9 | Real-time |
| 1 day | -1.45% | ||
| 1 week | +0.99% | ||
| Current month | +10.57% | ||
| 1 month | +7.09% | ||
| 3 months | -23.31% | ||
| 6 months | +2.26% | ||
| Current year | +7.37% |
| 1 week | 1.95 |  | 2.19 |
| 1 month | 1.65 | | 2.22 |
| Current year | 1.6 | | 3.4 |
| 1 year | 1.6 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 12 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 31/01/2026 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 12/04/2026 |
| Chief Tech/Sci/R&D Officer | - | 26/08/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 14/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 18/12/2016 |
| Director/Board Member | 71 | 18/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/07/26 | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 01/04/26 | Sell | Responsable ventes & marketing | 40,000 | 0.0165% | ||
| 30/12/25 | Buy | Chairman | 20,000 | 0.0082% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.45% | +0.99% | -13.92% | -40.87% | 51.99M | |
| -0.65% | -3.79% | +47.85% | +90.24% | 1,001B | |
| -0.29% | -4.62% | +51.08% | +65.41% | 642B | |
| +0.83% | -1.19% | +21.49% | +72.54% | 451B | |
| -0.38% | -3.45% | +29.35% | +34.09% | 340B | |
| -0.09% | -14.68% | +11.22% | +27.14% | 263B | |
| -0.43% | -3.61% | -1.73% | +7.95% | 247B | |
| -1.34% | -15.03% | +35.49% | +45.45% | 207B | |
| -3.44% | -8.32% | -21.27% | -59.20% | 197B | |
| -0.75% | -4.96% | +24.70% | +89.11% | 180B | |
| Average | -0.73% | -4.73% | +18.42% | +33.19% | 352.64B | |
| Weighted average by Cap. | -0.40% | -4.65% | +31.32% | +56.55% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 45.58M 39.3M 37.19M 33.69M 63.21M 4.35B 63.58M 441M 170M 2.21B 171M 167M 7B | 53.9M 46.48M 43.99M 39.85M 74.76M 5.15B 75.2M 522M 201M 2.62B 202M 198M 8.28B |
| Net income | -53.18M -45.86M -43.4M -39.31M -73.75M -5.08B -74.19M -515M -198M -2.58B -200M -195M -8.17B | -51.89M -44.75M -42.35M -38.36M -71.97M -4.96B -72.39M -503M -193M -2.52B -195M -191M -7.97B |
| Net Debt | -73.01M -62.96M -59.58M -53.98M -101M -6.98B -102M -707M -272M -3.55B -274M -268M -11.21B | -32.11M -27.69M -26.21M -23.74M -44.53M -3.07B -44.8M -311M -120M -1.56B -121M -118M -4.93B |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | SEK 2.040 | -1.45% | 47,335 |
| 10/09/26 | SEK 2.070 | -3.72% | 12,714 |
| 09/09/26 | SEK 2.150 | 0.00% | 47,561 |
| 08/09/26 | SEK 2.150 | +2.38% | 157,192 |
| 07/09/26 | SEK 2.100 | +3.96% | 149,511 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
